Investors Key figures Latest News More news 06.11.2024 Navamedic ASA: Mandatory notice of trade 06.11.2024 Navamedic launches Eroxon[®] in Finland 31.10.2024 Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business Share on: